<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pradal I</submitter><funding>Spanish National Research Council</funding><funding>Gobierno del Principado de Asturias</funding><pagination>179</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9860891</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>The rise of antimicrobial resistant (AMR) bacteria is a major health concern, especially with regard to members of the ESKAPE group, to which vancomycin-resistant (VRE) &lt;i>Enterococcus faecium&lt;/i> belongs. Phage therapy has emerged as a novel alternative for the treatment of AMR infections. This, however, relies on the isolation and characterisation of a large collection of phages. This work describes the exploration of human faeces as a source of new &lt;i>E. faecium&lt;/i>-infecting phages. Phage vB_EfaH_163 was isolated and characterised at the microbiological, genomic, and functional levels. vB_EfaH_163 phage, a new member of &lt;i>Herelleviridae&lt;/i>, subfamily &lt;i>Brockvirinae&lt;/i>, has a dsDNA genome of 150,836 bp that does not harbour any virulence factors or antibiotic resistance genes. It in</pubmed_abstract><journal>Viruses</journal><pubmed_title>&lt;i>Enterococcus faecium&lt;/i> Bacteriophage vB_EfaH_163, a New Member of the &lt;i>Herelleviridae&lt;/i> Family, Reduces the Mortality Associated with an &lt;i>E. faecium&lt;/i> vanR Clinical Isolate in a &lt;i>Galleria mellonella&lt;/i> Animal Model.</pubmed_title><pmcid>PMC9860891</pmcid><funding_grant_id>AYUD/2021/50916</funding_grant_id><funding_grant_id>CSIC201870I091</funding_grant_id><pubmed_authors>Pradal I</pubmed_authors><pubmed_authors>Del Rio B</pubmed_authors><pubmed_authors>Fernandez M</pubmed_authors><pubmed_authors>Casado A</pubmed_authors><pubmed_authors>Ladero V</pubmed_authors><pubmed_authors>Rodriguez-Lucas C</pubmed_authors><pubmed_authors>Alvarez MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>Enterococcus faecium&lt;/i> Bacteriophage vB_EfaH_163, a New Member of the &lt;i>Herelleviridae&lt;/i> Family, Reduces the Mortality Associated with an &lt;i>E. faecium&lt;/i> vanR Clinical Isolate in a &lt;i>Galleria mellonella&lt;/i> Animal Model.</name><description>The rise of antimicrobial resistant (AMR) bacteria is a major health concern, especially with regard to members of the ESKAPE group, to which vancomycin-resistant (VRE) &lt;i>Enterococcus faecium&lt;/i> belongs. Phage therapy has emerged as a novel alternative for the treatment of AMR infections. This, however, relies on the isolation and characterisation of a large collection of phages. This work describes the exploration of human faeces as a source of new &lt;i>E. faecium&lt;/i>-infecting phages. Phage vB_EfaH_163 was isolated and characterised at the microbiological, genomic, and functional levels. vB_EfaH_163 phage, a new member of &lt;i>Herelleviridae&lt;/i>, subfamily &lt;i>Brockvirinae&lt;/i>, has a dsDNA genome of 150,836 bp that does not harbour any virulence factors or antibiotic resistance genes. It in</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-06-28T03:08:50.357Z</modification><creation>2024-11-15T19:59:11.095Z</creation></dates><accession>S-EPMC9860891</accession><cross_references><pubmed>36680219</pubmed><doi>10.3390/v15010179</doi></cross_references></HashMap>